PMID- 20859200 OWN - NLM STAT- MEDLINE DCOM- 20110304 LR - 20161125 IS - 1473-5830 (Electronic) IS - 0954-6928 (Linking) VI - 21 IP - 8 DP - 2010 Dec TI - Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. PG - 455-9 LID - 10.1097/MCA.0b013e32833fd29b [doi] AB - BACKGROUND: The degree of coronary collateral development is not same in every patient with similar degree of coronary stenosis. In animal studies monocyte chemoattractant protein-1 (MCP-1) has been found to be related to collateral vessel development. In this study we investigated whether a higher serum MCP-1 level is related to better coronary collateral vessel development in patients with stable coronary artery disease. METHOD: Eighty-three patients with stable angina pectoris, who have at least one coronary stenosis equal to or greater than 70% at coronary angiography, were prospectively enrolled. Serum MCP-1 and vascular endothelial growth factor (VEGF) levels were studied. Coronary collateral development was graded according to the Rentrop method. Patients with grade 2-3 collateral developments were included in good collateral group and formed group I. The patients with grade 0-1 collateral developments were included in poor collateral group and formed group II. RESULTS: The serum MCP-1 level was significantly higher in good collateral group (288 +/- 277 pg/ml vs. 132 +/- 64 pg/ml; P<0.001). There was also a positive correlation between serum MCP-1 level and Rentrop score (r=0.39, P<0.001). The patients in the good collateral group also had a significantly higher number of coronary arteries with significant stenosis (1.7 +/- 0.7 vs. 1.4 +/- 0.6, P=0.049), and higher VEGF levels (322 +/- 147 pg/ml vs. 225 +/- 161 pg/ml, P=0.007). In multivariate analysis, only serum MCP-1 level (P=0.014, odds ratio: 1.01, 95% confidence interval: 1.002-1.019) was independently related to good coronary collateral development. CONCLUSION: Higher serum MCP-1 level is related to better coronary collateral development. FAU - Sahinarslan, Asife AU - Sahinarslan A AD - Department of Cardiology, School of Medicine, Gazi University, Ankara, Turkey. asifesah@yahoo.com FAU - Kocaman, Sinan A AU - Kocaman SA FAU - Topal, Salih AU - Topal S FAU - Ercin, Ugur AU - Ercin U FAU - Bukan, Neslihan AU - Bukan N FAU - Yalcin, Ridvan AU - Yalcin R FAU - Timurkaynak, Timur AU - Timurkaynak T LA - eng PT - Journal Article PL - England TA - Coron Artery Dis JT - Coronary artery disease JID - 9011445 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (VEGFA protein, human) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Aged MH - Biomarkers/blood MH - Chemokine CCL2/*blood MH - *Collateral Circulation MH - Coronary Angiography MH - *Coronary Circulation MH - Coronary Stenosis/*blood/diagnostic imaging/*physiopathology MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Male MH - Middle Aged MH - Prospective Studies MH - Severity of Illness Index MH - Turkey MH - Vascular Endothelial Growth Factor A/blood EDAT- 2010/09/23 06:00 MHDA- 2011/03/05 06:00 CRDT- 2010/09/23 06:00 PHST- 2010/09/23 06:00 [entrez] PHST- 2010/09/23 06:00 [pubmed] PHST- 2011/03/05 06:00 [medline] AID - 10.1097/MCA.0b013e32833fd29b [doi] PST - ppublish SO - Coron Artery Dis. 2010 Dec;21(8):455-9. doi: 10.1097/MCA.0b013e32833fd29b.